http://siegwartlab.com/Dr. Daniel J. Siegwart currently holds the W. Ray Wallace Distinguished Chair in Molecular Oncology Research and is a tenured Professor in the Department of Biomedical Engineering, Department of Biochemistry, and the Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center. He received a B.S. in Biochemistry from Lehigh University in 2003, and a Ph.D. in Chemistry from Carnegie Mellon University (CMU) in 2008 under the supervision of University Professor Krzysztof Matyjaszewski. During his graduate studies, he received the Joseph A. Solomon Memorial Fellowship in Chemistry at CMU and was a National Science Foundation East Asia and Pacific Summer Institutes Fellow at The University of Tokyo in 2006 with Professor Kazunori Kataoka. He then completed a National Institutes of Health NRSA-sponsored Postdoctoral Fellowship at Massachusetts Institute of Technology with Professor Daniel G. Anderson and Institute Professor Robert Langer (2008-2012). He is the Director of the Program in Genetic Drug Engineering, Director of the Drug Delivery Program in Biomedical Engineering, and Co-leader of the Chemistry and Cancer Program in the NCI-designated SCCC. The Siegwart Lab at UTSW designs and develops synthetic nanoparticle carriers for delivery of genomic medicines to targeted tissues and cells. Their research is grounded in chemical design and takes advantage of the unique opportunities for collaborative research at UT Southwestern. They ultimately aspire to utilize chemistry and engineering to make a beneficial impact on human health.